Related Experiment Video
Updated: May 1, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
What is new in HIV infection?
Kevin Sherin1, Benjamin G Klekamp2, Jeffery Beal3
1Florida State University College of Medicine, Orlando, FL, USA.
Routine human immunodeficiency virus (HIV) screening is recommended for all adults, with new testing and prevention strategies like pre-exposure prophylaxis (PrEP) significantly impacting HIV care. Treatment as prevention, utilizing combination antiretroviral therapy, is key to reducing viral loads and community transmission.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Medicine
Background:
- Updated guidelines recommend routine human immunodeficiency virus (HIV) screening for individuals aged 15-65, irrespective of risk factors.
- Fourth-generation HIV testing is now standard, improving the detection of acute infections and replacing older methods like the Western blot.
- The U.S. Food and Drug Administration has approved an in-home HIV test, though concerns regarding sensitivity and counseling exist.
Purpose of the Study:
- To summarize recent advancements and shifts in human immunodeficiency virus (HIV) prevention and treatment strategies.
- To highlight the evolving landscape of HIV screening, testing technologies, and prophylactic interventions.
- To underscore the significance of combination antiretroviral therapy (cART) in both treatment and prevention.
Main Methods:
- Review of current clinical recommendations and guidelines from authoritative bodies.
- Analysis of emerging diagnostic technologies, including fourth-generation assays and home-testing kits.
- Evaluation of evidence supporting pre-exposure prophylaxis (PrEP) and combination antiretroviral therapy (cART) for HIV prevention and treatment.
Main Results:
- Routine HIV screening is now broadly recommended, with fourth-generation tests enhancing early detection.
- Pre-exposure prophylaxis (PrEP) shows efficacy in high-risk groups but requires strict adherence and addresses misconceptions.
- Combination antiretroviral therapy (cART) is effective for treatment at any CD4 count and as a prevention strategy, lowering community viral loads.
Conclusions:
- A paradigm shift in HIV management emphasizes 'treatment is prevention,' with cART playing a central role.
- Early initiation of cART, guided by resistance testing, is crucial for all patients upon entering care.
- Special considerations are necessary for initiating cART in patients with specific opportunistic infections like tuberculosis and cryptococcal meningitis.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Size and Structure of Viral Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Mutations
Retroviruses

